1. Home
  2. CREX vs DYAI Comparison

CREX vs DYAI Comparison

Compare CREX & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CREX
  • DYAI
  • Stock Information
  • Founded
  • CREX N/A
  • DYAI 1979
  • Country
  • CREX United States
  • DYAI United States
  • Employees
  • CREX N/A
  • DYAI N/A
  • Industry
  • CREX EDP Services
  • DYAI Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CREX Technology
  • DYAI Health Care
  • Exchange
  • CREX Nasdaq
  • DYAI Nasdaq
  • Market Cap
  • CREX 33.5M
  • DYAI 31.3M
  • IPO Year
  • CREX N/A
  • DYAI 2004
  • Fundamental
  • Price
  • CREX $3.36
  • DYAI $0.99
  • Analyst Decision
  • CREX Strong Buy
  • DYAI Strong Buy
  • Analyst Count
  • CREX 2
  • DYAI 1
  • Target Price
  • CREX $8.00
  • DYAI $6.00
  • AVG Volume (30 Days)
  • CREX 188.5K
  • DYAI 36.6K
  • Earning Date
  • CREX 05-14-2025
  • DYAI 05-14-2025
  • Dividend Yield
  • CREX N/A
  • DYAI N/A
  • EPS Growth
  • CREX N/A
  • DYAI N/A
  • EPS
  • CREX N/A
  • DYAI N/A
  • Revenue
  • CREX $48,303,000.00
  • DYAI $3,554,344.00
  • Revenue This Year
  • CREX $10.03
  • DYAI $22.56
  • Revenue Next Year
  • CREX $18.84
  • DYAI $30.95
  • P/E Ratio
  • CREX N/A
  • DYAI N/A
  • Revenue Growth
  • CREX 1.68
  • DYAI 57.59
  • 52 Week Low
  • CREX $1.28
  • DYAI $0.93
  • 52 Week High
  • CREX $5.20
  • DYAI $2.67
  • Technical
  • Relative Strength Index (RSI)
  • CREX 68.78
  • DYAI 39.68
  • Support Level
  • CREX $2.80
  • DYAI $0.95
  • Resistance Level
  • CREX $3.64
  • DYAI $1.13
  • Average True Range (ATR)
  • CREX 0.46
  • DYAI 0.08
  • MACD
  • CREX 0.05
  • DYAI 0.00
  • Stochastic Oscillator
  • CREX 72.40
  • DYAI 30.00

About CREX Creative Realities Inc.

Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.

About DYAI Dyadic International Inc.

Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

Share on Social Networks: